Clinical Use of Captopril in Takayasu's Disease

Ehud Grossman, Benyamina Morag, Naomi Nussinovitch, Hayim Boichis, Aaron Knecht, Talma Rosenthal

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Abstract

Three patients with Takayasu's disease (TD), initially observed with hypertension and/or congestive heart failure, were treated with captopril, an orally active inhibitor of converting enzyme. As arteritis in this disease is diffuse and extensive, surgical correction of renovascular hypertension is often delayed or impossible. Our experience enables us to recommend captopril for conservative treatment in TD.

Original languageEnglish
Pages (from-to)95-96
Number of pages2
JournalArchives of Internal Medicine
Volume144
Issue number1
DOIs
StatePublished - Jan 1984
Externally publishedYes

Fingerprint

Dive into the research topics of 'Clinical Use of Captopril in Takayasu's Disease'. Together they form a unique fingerprint.

Cite this